Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) CEO Brian Goff sold 18,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 30th. The shares were sold at an average price of $27.09, for a total value of $506,664.27. Following the completion of the sale, the chief executive officer owned 136,583 […]

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) CEO Bobak Azamian sold 6,000 shares of Tarsus Pharmaceuticals stock in a transaction that occurred on Wednesday, December 24th. The stock was sold at an average price of $82.51, for a total value of $495,060.00. Following the transaction, the chief executive officer owned 857,991 shares in the […]

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) insider Najat Khan sold 124,403 shares of Recursion Pharmaceuticals stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $4.41, for a total value of $548,617.23. Following the completion of the sale, the insider directly owned 611,135 shares […]

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) VP Padmanabh Bhatt sold 710 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $44.44, for a total value of $31,552.40. Following the transaction, the vice president directly owned 14,508 shares of the company’s […]